Merck & Co., Inc. Stake Reduced by ABN AMRO Bank N.V.

ABN AMRO Bank N.V., an investment firm, reduced its stake in Merck & Co., Inc. by 7.6% during the second quarter, according to a recent SEC filing.

The fund owned 136,228 shares of MRK stock after selling 11,149 shares during the quarter. The value of ABN AMRO's holdings in Merck & Co., Inc. was $17,491,000 at the end of the most recent reporting period.

Merck & Co., Inc. had a return on equity of 16.73% and a net margin of 4.77%. The company's revenue for the quarter was up 5.1% compared to the same quarter last year, with earnings per share at ($0.13) topping analysts' estimates of ($0.26).